Showing results (171-180 of 307) with videos related to

Sort By:
Pageof 31
Movement Disorders : Official Journal of the Movement Disorder Society|April 28, 2006
Use of nutritional supplements in Parkinson's disease patientsSummer C Wolfrath, Amy R Borenstein, Skai Schwartz, et al.
The International Journal of Neuroscience|December 7, 2016
Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's diseaseElise G Valdés, Melissa L O'Connor, Ergun Y Uc, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2005
Chorea in a patient with cerebral palsy: treatment with levetiracetamMaria V Recio, Robert A Hauser, Elan D Louis, et al.
Frontiers in Neurology|October 26, 2020
Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical StudiesAlberto Esquenazi, Mauricio R Delgado, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Substantial improvement in a Meige's syndrome patient with levetiracetam treatmentTheresa A Zesiewicz, Elan D Louis, Kelly L Sullivan, et al.
Clinical Rheumatology|October 17, 2007
Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1Theresa A Zesiewicz, W Reed Shimberg, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2016
Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's diseaseRobert A Hauser, C Warren Olanow, Bruce Dzyngel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2008
Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's diseaseRobert A Hauser, Mark F Lew, Howard I Hurtig, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2013
Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's diseasePeter A LeWitt, F Jacob Huff, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremorTheresa A Zesiewicz, Christopher L Ward, Robert A Hauser, et al.
Pageof 31